SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-22-025324
Filing Date
2022-09-08
Accepted
2022-09-08 09:11:27
Documents
1
Period of Report
2022-08-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 3496
  Complete submission text file 0001493152-22-025324.txt   4902
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850
Business Address
Dritschilo Anatoly (Reporting) CIK: 0001945126 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41488 | Film No.: 221232691